Bharat Biotech seeks EUA for Covaxin
No date has been fixed as on when the SEC will meet for assessing and evaluating the applications, as per sources
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
ICMR
Homegrown COVID-19 vaccine final trials may conclude within two months: India
ICMR and Bharat Biotech month started third-stage trials of COVAXIN, in a process that would involve 26,000 volunteers
Bharat Biotech commences Phase III trials for COVAXIN
Phase III trials will involve 26,000 volunteers across India who will receive two intramuscular injections, approximately 28 days…
1600 participants enrolled for Phase III clinical trials of Covishield
SII and ICMR are conducting Phase 2/3 clinical trial of COVISHIELD at 15 different centres, across the country
Dalmia Healthcare nod from AYUSH Ministry to manufacture Astha-15 for COVID-19 treatment
Dalmia Healthcare would be applying for permission/approval of Astha-15 usage in allopathic hospitals, as per the procedure in…
Industry experts disagree with NPPA’s remark on FDCs
Experts say it is beyond the jurisdiction of NPPA
Covaxin may get launched in February 2021: ICMR scientist
The company had earlier hoped to launch it only in the second quarter of next year.
Bharat Biotech plans Covaxin launch in second quarter of 2021, post requisite approvals
Immediate focus is to conduct Phase 3 trial successfully
Bharat Biotech in talks with many countries for clinical trials, manufacture of COVAXIN
The countries are located in South America, Asia and Central Asia, and Eastern Europe
Dr Harsh Vardhan releases National Clinical Management Protocol based on Ayurveda and Yoga for…
the efforts of the government in promotion of AYUSH with ‘The National Commission for Indian System of Medicine Bill, 2020’ and…